The combination of Simvastatin and metformin influences the expression of GLUT1 and GLUT6 in glioma cells, inhibits malignant proliferation, and promotes apoptosis, providing novel ideas for the combination treatment of gliomas [68]. Here, SLC2A1 is linked to central nervous system cancer.